November 15, 2022

Walmart has agreed to pay $3.1 billion for its failure to oversee opioid dispensing in its pharmacies, helping to fuel the opioid crisis. Walmart will implement better policies and procedures and submit to increased oversight. Much of the settlement funding is designated for opioid treatment and recovery services, in addition to creating a Controlled Substance Compliance Director to oversee the settlement’s requirements. CA AG; NY AG; OR AG; DE AG; VA AG; KS AG

Tagged in: Pharma Fraud,